Our research

Driving global health through pharmacological research & innovation, and digital solutions.

Research that drives progress

Innopharma is a multidisciplinary and trans-departmental group with over 25 years of experience. Based at the University of Santiago de Compostela (USC), our team works across two main areas, Cellular Biology and Pharmacology, being our research topics:

Membrane biochemistry and signal transduction, largely applied to neurological and psychiatric studies.
Identification of targets and biomarkers for psychiatric treatment in schizophrenia.
Proteomic study of platelet signaling for cardiovascular disease.
Development of new HTS techniques.
Implementation of IT for continuous training of healthcare professionals.

Innopharma’s R&I combines and is nurtured by cutting-edge applied science research, making a significant impact on the quality of biomedical research. Alongside our independent projects, we maintain a strong track record of collaborative research with academic institutions, biotech firms, and the pharmaceutical industry.

Prof. Mabel Loza

Co-PI

“All our research is geared towards providing solutions for patients.”

Prof. Ángel Carracedo

Co-PI

“Common diseases are stratifying into rare diseases. To address this, genomics and coordinated international research are absolutely key.”

Our accomplishments

200+ publications

50+ public projects

30+ private collaborations

23 Ph.D. projects

3 spin-offs

Research lines

Molecular pharmacology of G-protein coupled receptors (GPCRs)

Studying GPCR expression and function in schizophrenia to identify molecular mechanisms and drug response alterations.

Pharmacology in translational research

Using pharmacogenomics and proteomics to discover schizophrenia biomarkers and personalize psychiatric drug therapies.

Fine-tuning and miniaturization of techniques for High Throughput Screening (HTS)

Designing, automating, and executing drug screening techniques for identifying pharmacological targets and compound activity.

New technologies (IT) applied to continual training of health professionals in pharmacology

Developing digital tools and platforms for ongoing pharmacist training in pharmaceutical care and drug dispensing.

Platelet proteomics research to study platelet signalling and cardiovascular disease

Investigating platelet signaling pathways to discover new cardiovascular disease biomarkers and therapeutic approaches.

Projects

Discover the projects where our research is collaboratively involved

EU-OPENSCREEN

CHAPRION

Aplicación de nuevos paradigmas en la farmacología molecular de los GPCRs

Desarrollo de Modelos Fenotípicos In Vitro de Dolor y su Aplicación al Cibrado de Compuestos de Alto Rendimiento

Discover our results in our scientific publications and more

Our spin-offs & patents

Celtarys develops innovative fluorescence-based chemical tools to enhance High Throughput Screening (HTS) in early drug discovery.

Pharmatools creates digital solutions to train pharmacists and healthcare professionals in improving the assessment of conditions treatable without prescription drugs.

Genomics, Genetics and Health.